206 related articles for article (PubMed ID: 31724682)
1. Comparison of bulk and microfluidic methods to monitor the phase behaviour of nanoparticles during digestion of lipid-based drug formulations using in situ X-ray scattering.
Hong L; Sesen M; Hawley A; Neild A; Spicer PT; Boyd BJ
Soft Matter; 2019 Nov; 15(46):9565-9578. PubMed ID: 31724682
[TBL] [Abstract][Full Text] [Related]
2. Compartmentalised enzyme-induced phase transformations in self-assembling lipid systems.
He V; Seibt S; Cadarso VJ; Neild A; Boyd BJ
J Colloid Interface Sci; 2024 Oct; 672():256-265. PubMed ID: 38838633
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive characterization of nanostructured lipid carriers using laboratory and synchrotron X-ray scattering and diffraction.
Tetyczka C; Hodzic A; Kriechbaum M; Juraić K; Spirk C; Hartl S; Pritz E; Leitinger G; Roblegg E
Eur J Pharm Biopharm; 2019 Jun; 139():153-160. PubMed ID: 30905779
[TBL] [Abstract][Full Text] [Related]
4. In Situ Lipolysis and Synchrotron Small-Angle X-ray Scattering for the Direct Determination of the Precipitation and Solid-State Form of a Poorly Water-Soluble Drug During Digestion of a Lipid-Based Formulation.
Khan J; Hawley A; Rades T; Boyd BJ
J Pharm Sci; 2016 Sep; 105(9):2631-2639. PubMed ID: 26359590
[TBL] [Abstract][Full Text] [Related]
5. Advances in microfluidic synthesis and coupling with synchrotron SAXS for continuous production and real-time structural characterization of nano-self-assemblies.
Ilhan-Ayisigi E; Yaldiz B; Bor G; Yaghmur A; Yesil-Celiktas O
Colloids Surf B Biointerfaces; 2021 May; 201():111633. PubMed ID: 33639513
[TBL] [Abstract][Full Text] [Related]
6. Evolution of the structure of lipid nanoparticles for nucleic acid delivery: From in situ studies of formulation to colloidal stability.
Gilbert J; Sebastiani F; Arteta MY; Terry A; Fornell A; Russell R; Mahmoudi N; Nylander T
J Colloid Interface Sci; 2024 Apr; 660():66-76. PubMed ID: 38241872
[TBL] [Abstract][Full Text] [Related]
7. Microfluidic Nanomaterial Synthesis and In Situ SAXS, WAXS, or SANS Characterization: Manipulation of Size Characteristics and Online Elucidation of Dynamic Structural Transitions.
Yaghmur A; Hamad I
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889473
[TBL] [Abstract][Full Text] [Related]
8. Solubilisation behaviour of poorly water-soluble drugs during digestion of solid SMEDDS.
Vithani K; Hawley A; Jannin V; Pouton C; Boyd BJ
Eur J Pharm Biopharm; 2018 Sep; 130():236-246. PubMed ID: 29981444
[TBL] [Abstract][Full Text] [Related]
9. Structural development of self nano emulsifying drug delivery systems (SNEDDS) during in vitro lipid digestion monitored by small-angle X-ray scattering.
Fatouros DG; Deen GR; Arleth L; Bergenstahl B; Nielsen FS; Pedersen JS; Mullertz A
Pharm Res; 2007 Oct; 24(10):1844-53. PubMed ID: 17458683
[TBL] [Abstract][Full Text] [Related]
10. Novel in situ setup to study the formation of nanoparticles in the gas phase by small angle x-ray scattering.
Shyjumon I; Rappolt M; Sartori B; Amenitsch H; Laggner P
Rev Sci Instrum; 2008 Apr; 79(4):043905. PubMed ID: 18447533
[TBL] [Abstract][Full Text] [Related]
11. Correction: Comparison of bulk and microfluidic methods to monitor the phase behaviour of nanoparticles during digestion of lipid-based drug formulations using in situ X-ray scattering.
Hong L; Sesen M; Hawley A; Neild A; Spicer PT; Boyd BJ
Soft Matter; 2020 Jan; 16(1):276. PubMed ID: 31815991
[TBL] [Abstract][Full Text] [Related]
12. Small-volume
Khan NF; Salim M; Binte Abu Bakar SY; Ristroph K; Prud'homme RK; Hawley A; Boyd BJ; Clulow AJ
Int J Pharm X; 2022 Dec; 4():100113. PubMed ID: 35243327
[TBL] [Abstract][Full Text] [Related]
13. The distribution of cell-penetrating peptides on polymeric nanoparticles prepared using microfluidics and elucidated with small angle X-ray scattering.
Streck S; Clulow AJ; Nielsen HM; Rades T; Boyd BJ; McDowell A
J Colloid Interface Sci; 2019 Nov; 555():438-448. PubMed ID: 31400536
[TBL] [Abstract][Full Text] [Related]
14. Microfluidic Chips for In Situ Crystal X-ray Diffraction and In Situ Dynamic Light Scattering for Serial Crystallography.
Gicquel Y; Schubert R; Kapis S; Bourenkov G; Schneider T; Perbandt M; Betzel C; Chapman HN; Heymann M
J Vis Exp; 2018 Apr; (134):. PubMed ID: 29757285
[TBL] [Abstract][Full Text] [Related]
15. Characterizing an siRNA-Containing Lipid-Nanoparticle Prepared by a Microfluidic Reactor: Small-Angle X-ray Scattering and Cryotransmission Electron Microscopic Studies.
Aburai K; Hatanaka K; Takano S; Fujii S; Sakurai K
Langmuir; 2020 Oct; 36(42):12545-12554. PubMed ID: 32988200
[TBL] [Abstract][Full Text] [Related]
16. Does the commonly used pH-stat method with back titration really quantify the enzymatic digestibility of lipid drug delivery systems? A case study on solid lipid nanoparticles (SLN).
Heider M; Hause G; Mäder K
Eur J Pharm Biopharm; 2016 Dec; 109():194-205. PubMed ID: 27789354
[TBL] [Abstract][Full Text] [Related]
17. Small-angle X-ray scattering in droplet-based microfluidics.
Stehle R; Goerigk G; Wallacher D; Ballauff M; Seiffert S
Lab Chip; 2013 Apr; 13(8):1529-37. PubMed ID: 23429654
[TBL] [Abstract][Full Text] [Related]
18. Interaction between lamellar (vesicles) and nonlamellar lipid liquid-crystalline nanoparticles as studied by time-resolved small-angle X-ray diffraction.
Vandoolaeghe P; Barauskas J; Johnsson M; Tiberg F; Nylander T
Langmuir; 2009 Apr; 25(7):3999-4008. PubMed ID: 19714888
[TBL] [Abstract][Full Text] [Related]
19. Microfluidics: a transformational tool for nanomedicine development and production.
Garg S; Heuck G; Ip S; Ramsay E
J Drug Target; 2016 Nov; 24(9):821-835. PubMed ID: 27492254
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity of polymyxin-loaded solid lipid nanoparticles (PLX-SLN): Characterization of physicochemical properties and in vitro efficacy.
Severino P; Silveira EF; Loureiro K; Chaud MV; Antonini D; Lancellotti M; Sarmento VH; da Silva CF; Santana MHA; Souto EB
Eur J Pharm Sci; 2017 Aug; 106():177-184. PubMed ID: 28576561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
